Table 1 Baseline characteristics of patients included in the validation analysis.
Baseline characteristics | Cardioembolic (E1) N = 55 | Arterioembolic (E2) N = 27 |
|---|---|---|
Years of age [median (min; max)] | 72 (44; 88) | 67,5 (45; 81) |
Female sex [%] | 50,9 | 48,1 |
Vascular risk factors | ||
Arterial hypertension [%] | 76,4 | 81,5 |
Diabetes mellitus [%] | 25,5 | 29,6 |
Coronary artery disease [%] | 25,5 | 22,2 |
Atrial fibrillation [%] | 87,3 | 3,7 |
Hyperlipoproteinemia [%] | 20,0 | 22,2 |
History of smoking [%] | 16,4 | 51,9 |
Physical state on admission [median (min; max)] | ||
Body mass index [kg/m2] | 25,7 (19,1; 53,6) n = 52 | 27,7 (20,5; 36,1) n = 26 |
Systolic blood pressure [mmHg] | 144 (97; 240) | 165 (119; 190) |
Blood glucose [mg/dl] | 114 (68; 180) | 113,5 (97; 196) |
NIHSS | 14 (4; 37) n = 53 | 14,5 (4; 37) |
Laboratory data on admission [median (min; max)] | ||
Platelet count [/nl] | 218 (98; 373) | 245 (142; 430) |
Hematocrit [%] | 39 (21; 46) | 42 (33; 49) |
Premedication | ||
Antiplatelet therapy [%] | 49,1 | 29,6 |
Anticoagulation [%] | 20,0 | 3,7 |
Occlusion site | ||
On the right: ICA, MCA, carotid T occlusion [%] | 47,3 | 48,1 |
On the left: ICA, MCA, carotid T occlusion [%] | 38,2 | 44,4 |
Basilar artery [%] | 14,5 | 7,4 |
Thrombolytic therapy | ||
None [%] | 21,8 | 22,2 |
Bridging with Abciximab [%] | 29,1 | 25,9 |
Systemic application of rt-PA [%] | 49,1 | 51,9 |
Local application of rt-PA [%] | 10,9 | 7,4 |
Course of thrombectomy [median (min; max)] | ||
Duration: Symptom onset–recanalization [min] | 204 (87; 625) n = 47 | 229,5 (135; 575) n = 16 |
Recanalization time [min] | 52 (9; 169) n = 53 | 48,5 (17; 153) |
